Valuation: Mega Lifesciences

Market Cap 28.77B 852M 763M 702M 636M 1.19B 80.87B 1.21B 8.37B 3.36B 42.54B 3.2B 3.13B 134B P/E 2026 *
12.6x
P/E 2027 * 11.6x
Enterprise Value 24.15B 715M 640M 589M 534M 998M 67.89B 1.02B 7.02B 2.82B 35.71B 2.68B 2.63B 113B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.55x
Free-Float
38.66%
Yield 2026 *
5.4%
Yield 2027 * 5.78%
1 day+0.76%
1 week-4.35%
Current month-2.22%
1 month-4.35%
3 months-12.00%
6 months-6.38%
Current year-1.49%
1 week 32.5
Extreme 32.5
34.75
1 month 32.5
Extreme 32.5
34.75
Current year 31.5
Extreme 31.5
40
1 year 28.75
Extreme 28.75
40
3 years 24.3
Extreme 24.3
44.25
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 31/12/1987
Director of Finance/CFO 62 31/12/1996
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 31/12/1997
Director/Board Member 64 31/12/2012
Director/Board Member 73 31/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.76%-4.35% - - 847M
+3.18%+11.62%+68.31%+151.26% 1,224B
-0.28%+4.29%+45.54%+87.13% 662B
+1.22%+3.19%+29.16%+107.72% 514B
+0.42%+3.20%+54.15%+67.18% 388B
+2.43%+3.27%+73.88%+46.10% 361B
+1.12%+4.52%+35.30%+58.08% 302B
+6.96%+8.86%+11.27%+36.62% 271B
+1.18%+6.18%+59.72%+77.21% 249B
+3.31%+9.87%+44.75%+120.44% 205B
Average +2.10%+2.59%+46.90%+83.53% 464.09B
Weighted average by Cap. +2.11%+3.04%+51.29%+98.72%

Financials

2026 *2027 *
Net sales 14.33B 424M 380M 349M 317M 592M 40.28B 603M 4.17B 1.67B 21.19B 1.59B 1.56B 66.82B 15.5B 459M 411M 378M 342M 640M 43.56B 652M 4.51B 1.81B 22.91B 1.72B 1.69B 72.26B
Net income 2.24B 66.4M 59.46M 54.7M 49.56M 92.64M 6.3B 94.37M 652M 262M 3.32B 249M 244M 10.46B 2.49B 73.58M 65.9M 60.62M 54.93M 103M 6.99B 105M 723M 290M 3.68B 276M 270M 11.59B
Net Debt -4.62B -137M -122M -113M -102M -191M -12.98B -194M -1.34B -539M -6.83B -513M -502M -21.53B -4.72B -140M -125M -115M -104M -195M -13.27B -199M -1.37B -551M -6.98B -524M -513M -22.01B
Projected Income Statement - Annual - Mega Lifesciences
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
29/10/26 THB 33.00 +0.76% 1,122,700
29/10/26 THB 32.75 -3.68% 2,371,500
28/10/26 THB 34.00 0.00% 934,500
27/10/26 THB 34.00 -0.73% 2,093,700
26/10/26 THB 34.25 -0.72% 1,847,000
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Mega Lifesciences
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
33.00THB
Average target price
42.71THB
Spread / Average Target
+29.44%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Mega Lifesciences